HealthEquity, Inc. (HQY) Insider Trading Activity

NASDAQ$102.03
Market Cap
$8.44B
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
355 of 849
Rank in Industry
14 of 29

HQY Insider Trading Activity

HQY Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$11,942
2
14
Sells
$4,233,304
12
86

Related Transactions

Rajasekar SunilEVP Chief Prod & Strat Officer
2
$11,942
2
$13,309
$-1,367
Wellborn Gayle Furgursondirector
0
$0
2
$644,841
$-644,841
Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER
0
$0
3
$756,770
$-756,770
DILLON ADRIAN Tdirector
0
$0
1
$798,373
$-798,373
Ladd DelanoEVP, General Counsel
0
$0
3
$973,920
$-973,920
Rosner ElimelechEVP, CHIEF TECHNOLOGY OFFICER
0
$0
1
$1.05M
$-1.05M

About HealthEquity, Inc.

Headquartered in Draper, Utah, and established in 2002, HealthEquity, Inc. furnishes technology-powered service platforms to both individual consumers and employers across the United States. The company provides cloud-based solutions designed to assist individuals in overseeing their healthcare expenditures and savings. These platforms enable users to make informed decisions about their health finances, pay medical bills, compare treatment options and costs, access personalized benefits and clinical data, earn incentives for wellness, and grow …

Insider Activity of HealthEquity, Inc.

Over the last 12 months, insiders at HealthEquity, Inc. have bought $11,942 and sold $4.23M worth of HealthEquity, Inc. stock.

On average, over the past 5 years, insiders at HealthEquity, Inc. have bought $891,460 and sold $17.5M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Rajasekar Sunil (EVP Chief Prod & Strat Officer) — $11,942.

The last purchase of 108 shares for transaction amount of $9,756 was made by Rajasekar Sunil (EVP Chief Prod & Strat Officer) on 2026‑10‑15.

List of Insider Buy and Sell Transactions, HealthEquity, Inc.

2026-10-15PurchaseRajasekar SunilEVP Chief Prod & Strat Officer
108
0.0001%
$90.33
$9,756
+9.54%
2026-08-25SaleDILLON ADRIAN Tdirector
7,632
0.0091%
$104.61
$798,373
-10.31%
2026-08-24SaleRajasekar SunilEVP Chief Prod & Strat Officer
108
0.0001%
$105.60
$11,405
-10.31%
2026-07-10SaleFiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER
2,354
0.0028%
$95.00
$223,630
+2.33%
2026-07-08PurchaseRajasekar SunilEVP Chief Prod & Strat Officer
23
<0.0001%
$95.06
$2,186
+1.91%
2026-07-02SaleFiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER
2,470
0.0029%
$95.00
$234,650
+1.31%
2026-05-29SaleFiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER
3,142
0.0041%
$95.00
$298,490
+8.05%
2026-05-28SaleLadd DelanoEVP, General Counsel
7,500
0.0089%
$90.00
$675,000
+4.88%
2026-05-28SaleWellborn Gayle Furgursondirector
2,439
0.0029%
$90.00
$219,510
+4.88%
2026-04-22SaleRajasekar SunilEVP Chief Prod & Strat Officer
23
<0.0001%
$82.81
$1,905
+12.27%
2025-12-19SaleLadd DelanoEVP, General Counsel
1,500
0.0017%
$94.72
$142,080
-7.54%
2025-12-18SaleRosner ElimelechEVP, CHIEF TECHNOLOGY OFFICER
10,959
0.0127%
$95.45
$1.05M
-7.50%
2025-12-12SaleWellborn Gayle Furgursondirector
4,339
0.0051%
$98.03
$425,331
-8.63%
2025-11-20SaleLadd DelanoEVP, General Counsel
1,500
0.0018%
$104.56
$156,840
-11.10%
2025-10-20SaleLadd DelanoEVP, General Counsel
1,500
0.0017%
$92.07
$138,105
-2.70%
2025-10-07SaleFiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER
1,781
0.002%
$88.21
$157,102
+2.42%
2025-09-19SaleLadd DelanoEVP, General Counsel
6,000
0.0069%
$94.11
$564,647
-2.64%
2025-09-05SaleDilsaver Evelyn Sdirector
3,461
0.0041%
$93.30
$322,916
-0.02%
2025-07-07SaleFiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER
1,794
0.0021%
$101.73
$182,499
-12.08%
2025-06-09SaleRosner ElimelechEVP, CHIEF TECHNOLOGY OFFICER
13,000
0.0151%
$111.37
$1.45M
-18.08%
Total: 379
*Gray background shows transactions not older than one year

Insider Historical Profitability

23.03%
DILLON ADRIAN Tdirector
62395
0.0754%
$6.37M31
+19.74%
Rajasekar SunilEVP Chief Prod & Strat Officer
53405
0.0646%
$5.45M22
Sacks Ian
109630
0.1325%
$11.19M19
+36.9%
MOTT DARCY G
91052
0.1101%
$9.29M156
+36.9%
Neeleman StephenFOUNDER AND VICE CHAIRMAN
89769
0.1085%
$9.16M146
<0.0001%
SELANDER ROBERT Wdirector
84969
0.1027%
$8.67M14
<0.0001%
Kessler JonFormer Director
75000
0.0907%
$7.65M150
<0.0001%
Dilsaver Evelyn Sdirector
48208
0.0583%
$4.92M23
+45.04%
Medici Frankdirector
36138
0.0437%
$3.69M140
+36.9%
Parker Stuart B.director
19061
0.023%
$1.94M11
+47.2%
Jensen FrodeExecutive VP, GC & Corp. Secy.
3000
0.0036%
$306,090.0010
+36.9%
*Gray background shows insiders who have made transactions during last year

HQY Institutional Investors: Active Positions

Increased Positions276+49.73%8M+9.03%
Decreased Positions246-44.32%8M-8.94%
New Positions89New5MNew
Sold Out Positions58Sold Out1MSold Out
Total Postitions585+5.41%90M+0.09%

HQY Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$1.02M13.14%11.17M+441,876+4.12%2025-09-30
Vanguard Group Inc$796,521.0010.29%8.75M+243,549+2.86%2025-09-30
Wasatch Advisors Lp$574,440.007.42%6.31M+206,611+3.39%2025-09-30
Fmr Llc$317,814.004.11%3.49M-2M-30.76%2025-09-30
State Street Corp$286,888.003.71%3.15M-34,024-1.07%2025-09-30
Geode Capital Management, Llc$199,950.002.58%2.2M+48,383+2.25%2025-09-30
Invesco Ltd.$193,902.002.51%2.13M-236,706-10.01%2025-09-30
Aqr Capital Management Llc$160,672.002.08%1.76M+656,820+59.31%2025-09-30
Westfield Capital Management Co Lp$156,336.002.02%1.72M+451,450+35.68%2025-09-30
Brown Advisory Inc$146,192.001.89%1.61M-21,751-1.34%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

No data is available at this moment.

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.